Health
Key immune driver of pancreatic cancer points to combination treatment for slowing progression
Medical Xpress·November 17, 2026

Researchers from The University of Texas MD Anderson Cancer Center have discovered that the IL-18 inflammatory protein helps pancreatic tumors grow and evade the immune system, highlighting its potential as a therapeutic target for pancreatic cancer.
Read the full story at Medical Xpress →